Over 1.3 Million Kidney Disease Tablets Recalled Over Quality Issues
Taipei: The Taiwan Food and Drug Administration (TFDA) has mandated the recall of two batches of a medication specifically utilized by patients with chronic kidney disease due to identified quality-related